Pila Pharma   Report issue

For profit Phase 2
Founded: Malmo Sweden (2014)

Organization Overview

First Clinical Trial
2017
NCT03278158
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Mergers & Acquisitions

Historical Acquisition Tree